
BlossomHill Therapeutics fell 12.4% from $16.00 to $14.02, behind the S&P 500's −2.4%. Its worst day was Oct 6 (−13.3%), and its low came Nov 5 at $12.35.
Aug 7, 2026 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-8.75 missed the $-0.77 estimate on $0.00 revenue.
−4.0% · S&P 500 +0.1%
BlossomHill Therapeutics closed at its lowest level of the year, 22.8% below where the year started.
Story events cover the past 12 months · Times ET
−0.2% · S&P 500 −4.4%
EPS of $-1.29 missed the $-0.90 estimate on $0.00 revenue.
−5.5% · S&P 500 −0.4%
Where it ended: a close of $14.02 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 19, 2027 (EPS est. $-1.01).
Nothing in the past 12 months.
All BLSM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BLSM and SPY from Benzinga historical bars. Not investment advice.